the administration of calcitonin for 4-17 wk resulted in an amelioration of the clinical phenomena associated with paget 's disease , including bone pain , increased skeletal vascularity , congestive heart failure , and neurologic deficits secondary to skeletal impingement .
C0006668
calcitonin
C0029401
paget 's disease